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Letter to the Editor
Mendelian Randomization
Estimates May Be Inflated
Ference et al. (1), using a Mendelian randomization approach,
show that the genetic effect of a unit change in low-density
lipoprotein (LDL) on coronary heart disease (CHD) is much
larger than the increase in risk per unit LDL seen prospectively in
cohort studies or the similar-sized decrease in risk per unit LDL
seen with effective interventions. The authors ascribe this differ-
ence to the lifelong effects of low LDL and suggest that earlier
intervention to reduce LDL could be beneficial. This is quite
possible. However, the Mendelian randomization estimate given
for the genetic effect of a unit change in LDL on CHD depends
on the assumption that the association of genetic variants with
LDL is constant across life or changes consistently with the
association of genetic variants with CHD. If some aspect of aging
or ill health reduced only the genetic association with LDL, the
genetic effect of a unit change in LDL on CHD would be
overstated (2) because the Mendelian randomization genetic effect
of LDL on CHD was estimated as the association of genetic
variants with CHD divided by the association of genetic variants
with LDL. Most of the studies providing the estimate of genetic
variants with LDL concern middle-aged people (1), in whomLDL levels may be affected by factors such as aging, ill health,
treatment, or body mass index, potentially attenuating the true
association of genetic variants with LDL. Few studies have
examined whether genetic associations with LDL vary with aging
and ill health, but evidence exists that shows the association of
some of the relevant genetic variants with LDL can vary substan-
tially with age (3,4), with weaker associations seen in older people.
Thus, the findings reported may not be inconsistent with the
effects of a unit change in LDL on CHD seen in cohort studies
and randomized control trials. Instead of indicating the life-long
effects of LDL, these findings may be the result of reverse
causality weakening the genetic association with specifically
LDL and thereby inflating the estimate.
More generally, this study illustrates the difficulty with inter-
preting such as Mendelian randomization estimates. Mendelian
randomization studies are most suitable for refuting causality
rather than establishing the exact size of a causal effect. First, such
a Mendelian randomization estimate will only indicate the true
size of a causal effect if the level of over- or under-estimation of the
genetic associations with the exposure and outcome are similar
(and nondifferential). If the observed genetic association with the
exposure is more understated than that with the outcome, then the
estimate may be too large. Conversely, if the observed genetic
association with the exposure is less understated than that with the
outcome, then the estimate may be too small. Second, an exposure
could appear to be causal in a Mendelian randomization study if it
were a marker of an intermediate factor between genetic variants
and exposure that also caused the exposure and outcome. As such,
Mendelian randomization estimates should be interpreted as
hypothesis testing, that is, able to disprove a postulated causal
effect, rather than indicating the size or existence of a postulated
causal effect.
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Reply
We agree with Dr. Schooling and colleagues that interpreting the
magnitude of the association between a modifiable exposure such
